×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Medicine to Treat One Million People Arrives in Haiti

News

Haitian First Lady Sophia Martelly (second from left) and Health Minister Florence Duperval Guillaume (second from right) today announced the distribution of chikungunya treatment kits at Direct Relief's warehouse in Haiti.
By Hannah Rael

Medicine to treat one million people – or nearly one in 10 Haitians – have arrived at Direct Relief’s warehouse in Port-au-Prince as the mosquito-borne chikungunya virus continues to spread throughout the Americas.

Haitian First Lady Sophia Martelly and Health Minister Florence Duperval Guillaume were on site today to announce the distribution of treatment kits to centers around the country.

The shipment, designated for Haiti’s 904 Public Health and Population sites and Direct Relief’s other partner hospitals, contains more than 6.1 million Defined Daily Doses of pain relievers, oral rehydration packs, antibiotics, IV solution, malaria tablets, and mosquito spray. This distribution comes in the midst of a rainy season, expected to cause a wave of new cases.

Unlike many other mosquito-borne diseases, no vaccine is available to prevent chikungunya. Common symptoms include fever and joint pain, which is often severe and disabling.

The current outbreak, which began in late 2013, marked the arrival of chikungunya in the Americas. It was first detected in Haiti in May and its spread prompted the Haitian government to formally declare a medical emergency. Health officials anticipate that up to 50 percent of the population may be affected by the outbreak. To date, Haiti has recorded roughly 65,000 cases.

Generic pharmaceutical company Apotex generously donated more than $2.2 million of the $2.6 million (wholesale) in medical aid included in this delivery.

“When a fast-spreading virus like chikungunya impacts people who already struggle to access health care, it is important to provide hospitals and clinics with the supplies they need to meet the growing demand for care,” said Jeff Watson, Apotex’s President, US and Canada (Apotex Corp/Aveva/Apotex Inc.). “Apotex is in a position to help, and we are delighted to work with Direct Relief to fill those gaps.”

Other contributors to this response include Generic Pharmaceutical Association (GPHA) members Amneal, Hospira, and TEVA Pharmaceuticals, along with 3M, Johnson & Johnson, McNeil, McKesson, and Prestige Brands.

Since Haiti’s devastating earthquake in 2010, Direct Relief has worked with the Haitian Ministry of Public Health and Population to deliver more than $120 million in medical aid throughout the country.

Click here to support shipments like these. Your donations enable deliveries of life-saving medical supplies to people in need.

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.